Prof. Hao Chen | Biomedicine | Best Researcher Award
Associate Professor, Chief Physician, Supervisor at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China
Summary:
Prof. Hao Chen is an accomplished Associate Professor and Chief Physician of Neurosurgery at Shanghai Jiao Tong University School of Medicine, where he also serves as a graduate supervisor. He holds a Doctor of Medicine degree from the same institution and specializes in traumatic brain injury, stroke, and neurocritical care. His research interests include neuromodulation, brain-computer interfaces, and the integration of artificial intelligence in neurosurgery. Prof. Chen has received significant funding for his research, including grants from the National Natural Science Foundation of China. He has been recognized with several awards, including the “Wang Kuancheng” Medical Award and the AANS/CNS BrainLab Neurosurgery Award. Additionally, he is a visiting assistant professor at Vanderbilt University Medical Center and actively participates in professional organizations, contributing to advancements in neurosurgery and medical education. His work has been widely published in leading journals, underscoring his impact in the field.
Profile:
Education:
Prof. Hao Chen completed his Doctor of Medicine at Shanghai Jiao Tong University School of Medicine from September 2013 to July 2017. Prior to this, he earned his Master of Medicine from the same institution between September 2005 and July 2008. His academic journey began at Qingdao University School of Medicine, where he obtained his Bachelor of Clinical Medicine, graduating in July 2005. This comprehensive educational background has equipped him with a strong foundation in medical sciences, particularly in the field of neurosurgery.
Professional Experience:
Prof. Hao Chen has an extensive professional background in neurosurgery and medical education. Currently serving as an Associate Professor and Chief Physician of Neurosurgery at Shanghai Jiao Tong University School of Medicine, he also acts as a graduate supervisor and Vice Director of the Clinical Diagnosis and Treatment Center for Traumatic Brain Injury and Neurocritical Care. In addition to his primary role, Prof. Chen is a visiting assistant professor at Vanderbilt University Medical Center, where he collaborates on advanced research initiatives. He is actively involved in various professional committees, including the Peripheral Nerve Professional Committee of the Chinese Medical Doctor Association, and holds memberships in the American Congress of Neurological Surgeons and the International Brain Injury Association. His clinical expertise encompasses traumatic brain injury, intracerebral hemorrhage, glioblastoma, and neurosurgical intensive care, further demonstrating his commitment to improving patient outcomes and advancing the field of neurosurgery.
Research Interests:
Prof. Hao Chen’s research interests lie at the intersection of neurosurgery and advanced medical technologies. His primary focus includes traumatic brain injury (TBI), stroke, and neurocritical care, where he explores innovative approaches to improve patient management and recovery. He is particularly interested in neuromodulation techniques and the development of brain-computer interfaces that can enhance neurorehabilitation. Additionally, Prof. Chen is actively engaged in integrating artificial intelligence technologies into neurosurgery, aiming to optimize surgical outcomes and refine diagnostic processes. His work seeks to uncover the underlying mechanisms of neurological injuries and develop targeted therapeutic strategies, making significant contributions to the field of neurosurgical research and clinical practice.
Skills:
Prof. Hao Chen possesses a diverse array of skills that are integral to his role as a neurosurgeon and researcher. His clinical expertise encompasses advanced surgical techniques for managing traumatic brain injuries, intracerebral hemorrhages, and glioblastomas, ensuring optimal patient care in high-stakes environments. He is proficient in the application of neurocritical care protocols, emphasizing the importance of comprehensive patient management. In addition to his surgical acumen, Prof. Chen is skilled in utilizing neuromodulation therapies and brain-computer interfaces, showcasing his commitment to integrating innovative technologies into clinical practice. His research capabilities are bolstered by a strong foundation in grant writing, data analysis, and the implementation of clinical trials, enabling him to contribute effectively to the advancement of neurosurgical science and education. Furthermore, his collaborative spirit and leadership qualities foster interdisciplinary teamwork, essential for tackling complex medical challenges.
Conclution:
Prof. Hao Chen’s extensive educational background, current research focus on neurosurgery, substantial funding and awards, active participation in clinical trials, and impactful publications collectively position him as an outstanding candidate for the Research for Best Researcher Award. His dedication to advancing the field of neurosurgery through innovative research and clinical practices significantly contributes to improving patient outcomes and the broader scientific community.
Publication Top Noted:
- Transplantation of Astrocyte-Derived Mitochondria into Injured Astrocytes Has a Protective Effect Following Stretch Injury
Authors: Q.-Y. Gong, W. Wang, L. Cai, H. Chen, Z.-M. Xu
Journal: Mitochondrion
Volume: 78
Article Number: 101902
Year: 2024 - Endorepellin Downregulation Promotes Angiogenesis After Experimental Traumatic Brain Injury
Authors: Q. Zhang, Y. Jing, Q. Gong, J. Ding, Z. Xu
Journal: Neural Regeneration Research
Volume: 19(5)
Pages: 1092–1097
Year: 2024 - MiR-181b Promotes Angiogenesis and Neurological Function Recovery After Ischemic Stroke
Authors: L.-X. Xue, L.-Y. Shu, H.-M. Wang, Y.-W. Zhao, H. Chen
Journal: Neural Regeneration Research
Volume: 18(9)
Pages: 1983–1989
Year: 2023
Cited by: 5 - Inhibiting Phosphatase and Actin Regulator 1 Expression is Neuroprotective in the Context of Traumatic Brain Injury
Authors: Y. Jing, L. Zhang, S.-W. Chen, Z.-M. Xu, J. Ding
Journal: Neural Regeneration Research
Volume: 18(7)
Pages: 1578–1583
Year: 2023 - Glucose-Decorated Engineering Platelets for Active and Precise Tumor-Targeted Drug Delivery
Authors: J. Zhao, Y. Shi, L. Xue, H. Chen, M. Kong
Journal: Biomaterials Science
Volume: 11(11)
Pages: 3965–3975
Year: 2023
Cited by: 1 - Knockout of Sirt2 Alleviates Traumatic Brain Injury in Mice
Authors: W. Wang, Q.-Y. Gong, L. Cai, H. Chen, H.-L. Tian
Journal: Neural Regeneration Research
Volume: 18(2)
Pages: 350–356
Year: 2023
Cited by: 7 - ACT001 Attenuates Microglia-Mediated Neuroinflammation After Traumatic Brain Injury via Inhibiting AKT/NFκB/NLRP3 Pathway
Authors: L. Cai, Q. Gong, L. Qi, H. Chen, H. Tian
Journal: Cell Communication and Signaling
Volume: 20(1), Article 56
Year: 2022
Cited by: 46 - In Situ Injectable Nano-Complexed Hydrogel Based on Chitosan/Dextran for Combining Tumor Therapy via Hypoxia Alleviation and TAMs Polarity Regulation
Authors: W. Zhang, Y. Shi, H. Li, H. Chen, M. Kong
Journal: Carbohydrate Polymers
Volume: 288
Article Number: 119418
Year: 2022
Cited by: 22 - Upregulation of C Terminus of Hsc70-Interacting Protein Attenuates Apoptosis and Procoagulant Activity and Facilitates Brain Repair After Traumatic Brain Injury (Retracted)
Authors: H. Chen, Y. Jing, Z. Xu, H. Tian, L. Xue
Journal: Frontiers in Neuroscience
Volume: 14, Article 925
Year: 2020
Cited by: 4 - A Brain-Penetrating Hsp90 Inhibitor NXD30001 Inhibits Glioblastoma as a Monotherapy or in Combination With Radiation
Authors: H. Chen, Y. Gong, Y. Ma, Z. Cheng, L. Xue
Journal: Frontiers in Pharmacology
Volume: 11, Article 974
Year: 2020
Cited by: 15